The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Bone metastases from differentiated thyroid carcinoma
Open accessAbstract
The presence of distant metastases from differentiated thyroid carcinoma decreases the 10-year survival of patients by 50%. Bone metastases represent a frequent complication especially of follicular thyroid cancer and severely reduce the quality of life causing pain, fractures, and spinal cord compression. Diagnosis is established by correlating clinical suspicion with imaging. Imaging is essential to detect, localize, and assess the extension of the lesions and should be used in conjunction with clinical evidence. Bone metastases are typically associated with elevated markers of bone turnover, but these markers have not been evaluated in differentiated thyroid cancer. Skeletal and whole-body magnetic resonance imaging and fusion 2-deoxy-2-[18F]fluoro-D-glucose whole-body positron emission tomography/computed tomography (PET/CT) are the best anatomic and functional imaging techniques available in specialized centers. For well-differentiated lesions, iodine-PET scan combined (124)I-PET/CT is the newest imaging development and (131)I is the first line of treatment. Bisphosphonates reduce the complications rate and pain, alone or in combination with radioiodine, radionuclides, or external beam radiotherapy and should be employed. Surgery and novel minimally invasive consolidation techniques demand an appropriate patient selection for best results on a multimodal approach. Basic research on interactions between tumor cells and bone microenvironment are identifying potential novel targets for future more effective therapeutic interventions for less differentiated tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
Coleman, R. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0931 · Cited by 2,488
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, R. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0210 · Cited by 1,920
Durante, C., Haddy, N., Baudin, E., Leboulleux, S., Hartl, D., Travagli, J. P., Caillou, B., Ricard, M., Lumbroso, J. D., De Vathaire, F., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2838 · Cited by 1,675
Papillary and Follicular Thyroid Carcinoma
Schlumberger, M. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380506 · Cited by 1,623
Surgical Strategy for Spinal Metastases
Tomita, K., Kawahara, N., Kobayashi, T., Yoshida, A., Murakami, H., & Akamaru, T. (2001) · Spine · doi:10.1097/00007632-200102010-00016 · Cited by 1,404
Glinsky, G. V., Berezovska, O., & Glinskii, A. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23412 · Cited by 916
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.9.1382 · Cited by 877
Samaan, N. A. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.714 · Cited by 615
Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients
Fourney, D. R., Schomer, D. F., Nader, R., Chlan-Fourney, J., Suki, D., Ahrar, K., Rhines, L. D., & Gokaslan, Z. L. (2003) · Journal of Neurosurgery: Spine · doi:10.3171/spi.2003.98.1.0021 · Cited by 611
Robbins, R. J., Wan, Q., Grewal, R. K., Reibke, R., Gonen, M., Strauss, H. W., Tuttle, R. M., Drucker, W., & Larson, S. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1534 · Cited by 587
MARTIN, S., MAURICE, T., VATHAIRE, F. D., CATHERINE, H., GARDET, P., TRAVAGLI, J.-P., FRAGU, P., LUMBROSO, J., CAILLOU, B., & PARMENTIER, C. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-4-960 · Cited by 552
Porter, A. T., McEwan, A. J. B., Powe, J. E., Reid, R., McGowan, D. G., Lukka, H., Sathyanarayana, J. R., Yakemchuk, V. N., Thomas, G. M., Erlich, L. E., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90309-j · Cited by 534
Coleman, R. E., Major, P., Lipton, A., Brown, J. E., Lee, K.-A., Smith, M., Saad, F., Zheng, M., Hei, Y. J., Seaman, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.091 · Cited by 533
Schlumberger, M. J., Vathaire, C. C.-D., de Vathaire, F., Travagli, J. P., Gardet, P., Lumbroso, J., Francese, C., Fontaine, F., Ricard, M., & Parmentier, C. (1996) · PubMed · Cited by 498
The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer
Kebebew, E., Weng, J., Bauer, J., Ranvier, G., Clark, O. H., Duh, Q.-Y., Shibru, D., Bastian, B., & Griffin, A. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318148563d · Cited by 480
Shimaoka, K., Schoenfeld, D. A., Dewys, W. D., Creech, R. H., & Deconti, R. (1985) · Cancer · doi:10.1002/1097-0142(19851101)56:9<2155::aid-cncr2820560903>3.0.co;2-e · Cited by 464
First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases
Nilsson, S., Larsen, R. H., Fosså, S. D., Balteskard, L., Borch, K. W., Westlin, J.-E., Salberg, G., & Bruland, Ø. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2244 · Cited by 440
European Journal of Nuclear Medicine and Molecular Imaging
(2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/259.1619-7089 · Cited by 430
Critical determinants of metastasis
Fidler, I. J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0416 · Cited by 413
Tu, S.-M., Millikan, R. E., Mengistu, B., Delpassand, E. S., Amato, R. J., Pagliaro, L. C., Daliani, D., Papandreou, C. N., Smith, T. L., Kim, J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03639-4 · Cited by 396
RUEGEMER, J. J., HAY, I. D., BERGSTRALH, E. J., RYAN, J. J., OFFORD, K. P., & GORMAN, C. A. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-501 · Cited by 389
Bisphosphonates: Clinical Experience
Coleman, R. E. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-14 · Cited by 384
Body, J.-J., Greipp, P., Coleman, R. E., Facon, T., Geurs, F., Fermand, J.-P., Harousseau, J.-L., Lipton, A., Mariette, X., Williams, C. D., et al. (2003) · Cancer · doi:10.1002/cncr.11138 · Cited by 383
Tsang, R. W., Brierley, J. D., Simpson, W. J., Panzarella, T., Gospodarowicz, M. K., & Sutcliffe, S. B. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<389::aid-cncr19>3.0.co;2-v · Cited by 381
Radioisotopes for the palliation of metastatic bone cancer: a systematic review
Finlay, I. G., Mason, M. D., & Shelley, M. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70206-0 · Cited by 369
Wang, W. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1107 · Cited by 339
Endocrinology and Metabolism Clinics of North America
Galoiu, S. (2008) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2008.361 · Cited by 336
Traxler, P., Allegrini, P. R., Brandt, R., Brueggen, J., Cozens, R., Fabbro, D., Grosios, K., Lane, H. A., McSheehy, P., Mestan, J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3681 · Cited by 320
Antitumor effects of bisphosphonates
Green, J. R. (2003) · Cancer · doi:10.1002/cncr.11128 · Cited by 311
Sgouros, G., Kolbert, K. S., Sheikh, A., Pentlow, K. S., Mun, E. F., Barth, A., Robbins, R. J., & Larson, S. M. (2004) · PubMed · Cited by 308
Bernier, M.-O. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1568 · Cited by 299
Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
Simpson, W. J., Panzarella, T., Carruthers, J. S., Gospodarowicz, M. K., & Sutcliffe, S. B. J. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90381-1 · Cited by 275
Management of bone metastases in cancer: A review
Selvaggi, G., & Scagliotti, G. V. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.03.011 · Cited by 266
Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy
Dupuy, D. E., Monchik, J. M., Decrea, C., & Pisharodi, L. (2001) · Surgery · doi:10.1067/msy.2001.118708 · Cited by 239
Monchik, J. M., Donatini, G., Iannuccilli, J., & Dupuy, D. E. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217685.85467.2d · Cited by 234
Bisphosphonates and Cancer-Induced Bone Disease: Beyond Their Antiresorptive Activity
Clézardin, P., Ebetino, F. H., & Fournier, P. G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0264 · Cited by 232
RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis
Wittrant, Y., Théoleyre, S., Chipoy, C., Padrines, M., Blanchard, F., Heymann, D., & Rédini, F. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.05.002 · Cited by 231
External radiotherapy in thyroid cancers
Tubiana, M., Haddad, E., Schlumberger, M. J., Hill, C., Rougier, P. R., & Sarrazin, D. (1985) · Cancer · doi:10.1002/1097-0142(19850501)55:9+<2062::aid-cncr2820551406>3.0.co;2-o · Cited by 225
Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
Pandit-Taskar, N. D., Batraki, M., & Divgi, C. R. (2004) · PubMed · Cited by 224
Pittas, A. G., Adler, M., Fazzari, M., Tickoo, S., Rosai, J., Larson, S. M., & Robbins, R. J. (2000) · Thyroid · doi:10.1089/thy.2000.10.261 · Cited by 224
Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone
Pecheur, I., Peyruchaud, O., Serre, C., Guglielmi, J., Voland, C., Bourre, F., Margue, C., Cohen‐Solal, M., Buffet, A., Kieffer, N., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0911fje · Cited by 223
Casara, D., Rubello, D., Saladini, G., Masarotto, G., Favero, A., Girelli, M. E., & Busnardo, B. (1993) · PubMed · Cited by 212
Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT
Schmidt, G. P., Schoenberg, S. O., Schmid, R., Stahl, R., Tiling, R., Becker, C. R., Reiser, M. F., & Baur-Melnyk, A. (2007) · European Radiology · doi:10.1007/s00330-006-0361-8 · Cited by 209
Balloon kyphoplasty for the treatment of pathological vertebral compressive fractures
Gaitanis, I. N., Hadjipavlou, A. G., Katonis, P. G., Tzermiadianos, M. N., Pasku, D. S., & Patwardhan, A. G. (2005) · European Spine Journal · doi:10.1007/s00586-004-0767-4 · Cited by 196
Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
Pacini, F., Cetani, F., Miccoli, P., Mancusi, F., Ceccarelli, C., Lippi, F., Martino, E., & Pinchera, A. (1994) · World Journal of Surgery · doi:10.1007/bf00353775 · Cited by 175
Beierwaltes, W. H., Nishiyama, R. H., Thompson, N. W., Copp, J., & Kubo, A. (1982) · PubMed · Cited by 171
A Systematic Overview of Radiation Therapy Effects in Skeletal Metastases
Falkmer, U., Järhult, J., Wersäll, P., & Cavallin-ståhl, E. (2003) · Acta Oncologica · doi:10.1080/02841860310014895 · Cited by 168
Zettinig, G., Fueger, B. J., Passler, C., Kaserer, K., Pirich, C., Dudczak, R., & Niederle, B. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01482.x · Cited by 164
Aldred, M. A., Huang, Y. S., Liyanarachchi, S., Pellegata, N. S., Gimm, O., Jhiang, S. M., Davuluri, R. V., de la Chapelle, A., & Eng, C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.127 · Cited by 150
Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer
Freudenberg, L. S., Antoch, G., Jentzen, W., et al. (2004) · European Radiology · doi:10.1007/s00330-004-2350-0 · Cited by 121
Vitale, G., Fonderico, F., Martignetti, A., Caraglia, M., Ciccarelli, A., Nuzzo, V., Abbruzzese, A., & Lupoli, G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1832 · Cited by 119
Outcome of Palliative Embolization of Bone Metastases in Differentiated Thyroid Carcinoma
Eustatia‐Rutten, C. F. A., Romijn, J. A., Guijt, M., Vielvoye, G. J., van den Berg, R., Corssmit, E. P. M., Pereira, A. M., & Smit, J. W. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030231 · Cited by 118
Park, J., Zarnegar, R., Kanauchi, H., Wong, M. G., Hyun, W. C., Ginzinger, D. G., Lobo, M., Cotter, P. D., Duh, Q., & Clark, O. H. (2005) · Thyroid · doi:10.1089/thy.2005.15.222 · Cited by 102
Self-citationGeneral Principles of External Beam Radiation Therapy for Skeletal Metastases
Frassica, D. A. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093057.96273.fb · Cited by 102
Assessment of therapeutic response in patients with metastatic bone disease
Clamp, A. R., Danson, S. J., Nguyen, H. D., Cole, D. E. C., & Clemons, M. J. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01596-7 · Cited by 95
Zarnegar, R., Brunaud, L., Kanauchi, H., Wong, M. G., Fung, M., Ginzinger, D. G., Duh, Q., & Clark, O. H. (2002) · Surgery · doi:10.1067/msy.2002.128690 · Cited by 94
Self-citationSantini, F., Bottici, V., Elisei, R., Montanelli, L., Mazzeo, S., Basolo, F., Pinchera, A., & Pacini, F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011151 · Cited by 91
Morton, A. R., Cantrill, J. A., Pillai, G. V., McMahon, A., Anderson, D. C., & Howell, A. (1988) · BMJ · doi:10.1136/bmj.297.6651.772 · Cited by 87
Aldred, M. A., Ginn‐Pease, M. E., Morris, Q., Popkie, A. P., Gimm, O., Hoang‐Vu, C., Krause, U., Dralle, H., Jhiang, S. M., Plass, C., et al. (2003) · PubMed · Cited by 87
In Vitro and In Vivo Antitumor Effects of Bisphosphonates
Clézardin, P., Fournier, P. G. J., Boissier, S., & Peyruchaud, O. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368529 · Cited by 82
Schoenberger, J., Grimm, D. G., Kossmehl, P. P., Infanger, M., Kurth, E., & Eilles, C. (2003) · Endocrinology · doi:10.1210/en.2003-1228 · Cited by 81
van Tol, K. M., Hew, J. M., Jager, P. L., Vermey, A., Dullaart, R. P. F., & Links, T. P. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00998.x · Cited by 81
Rodolico, V., Cabibi, D., Pizzolanti, G., Richiusa, P., Gebbia, N., Martorana, A., Russo, A. D., Amato, M. C., Galluzzo, A., & Giordano, C. S. D. S. (2007) · Cancer · doi:10.1002/cncr.22912 · Cited by 79
Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis
Vasko, V. V., & Saji, M. (2006) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011ab86 · Cited by 72
Wexler, J. A., & Sharretts, J. M. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.04.005 · Cited by 72
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases
Storto, G., Klain, M., Paone, G., Liuzzi, R., Molino, L., Marinelli, A., Soricelli, A., Pace, L., & Salvatore, M. (2006) · Bone · doi:10.1016/j.bone.2005.12.004 · Cited by 68
Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo
Soh, E. Y., Eigelberger, M. S., Kim, K. J., Wong, M. G., Young, D. M., Clark, O. H., & Duh, Q. (2000) · Surgery · doi:10.1067/msy.2000.110430 · Cited by 56
Gorgoulis, V. G., Aninos, D., Priftis, C., Evagelopoulou, C., Karameris, A., Kanavaros, P., & Spandidos, D. A. (1992) · PubMed · Cited by 36
Kokufu, I., Taniguchi, H., Kim, Y. H., Fukuda, K., Yamamoto, M., Tokiharu, Y. A. N. O., Yamada, K., & KITANO, H. (2000) · PubMed · Cited by 1
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Smallridge, R. C., Ain, K. B., Asa, S. L., Bible, K. C., Brierley, J. D., Burman, K. D., Kebebew, E., Lee, N. Y., Nikiforov, Y. E., Rosenthal, M. S., et al. (2012) · Thyroid · doi:10.1089/thy.2012.0302 · Cited by 935
Engineered nanoparticles for biomolecular imaging
Mahmoudi, M., Serpooshan, V., & Laurent, S. (2011) · Nanoscale · doi:10.1039/c1nr10326a · Cited by 262
Metadata
- Authors
- Muresan, M. M., Olivier, P., Leclere, J., Sirveaux, F., Brunaud, L., Klein, M., Zarnegar, R., & Weryha, G.
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2008-03-01
- Volume
- 15
- Issue
- 1
- Pages
- 37-49
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2165969583
- Cited by
- 260
- References
- 73
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.